Table 1.
|
Total (%) |
Male (%) |
Female (%) |
|
---|---|---|---|---|
Clinical features | N = 102 | N = 82 | N = 20 | P value |
Sex |
|
|
|
|
Male |
82 (80.4) |
|
|
|
Female |
20 (19.6) |
|
|
|
Age (Year) |
|
|
|
0.348 |
Median [Range] |
68 [29-86] |
68 [29-84] |
72[29-86] |
|
29-49 |
18 (17.6) |
16 (19.5) |
2 (10.0) |
|
50-79 |
73 (71.6) |
59 (57.8) |
14 (70.0) |
|
79-86 |
11 (10.8) |
7 (8.5) |
4 (20.0) |
|
Location |
|
|
|
0.868 |
Upper |
27 (26.5) |
22 (26.8) |
5 (33.3) |
|
Middle + Lower |
75 (73.5) |
60 (73.2) |
15 (66.6) |
|
Operation method |
|
|
|
0.454 |
Partial |
64 (62.7) |
50 (61.0) |
14 (70.0) |
|
Total |
38 (37.3) |
32 (39.0) |
6 (30.0) |
|
Curability |
|
|
|
0.147 |
No residual tumors |
87 (85.3) |
72 (87.8) |
15 (75.0) |
|
Definite residual tumor |
15 (14.7) |
10 (12,2) |
5 (25.0) |
|
Clinical stage (TNM) |
|
|
|
0.563 |
Stage I-III |
82 (80.4) |
65 (79.3) |
17 (85.0) |
|
Stage IV |
20 (19.6) |
17 (20.7) |
3 (15.0) |
|
Histological stage (TNM) |
|
|
|
0.936 |
Stage II-III |
86 (84.3) |
69 (84.2) |
17 (85.0) |
|
Stage IV |
16 (15.7) |
13 (15.8) |
3 (15.0) |
|
Histological type |
|
|
|
|
Intestinal |
141 (100) |
82 (100) |
20 (100) |
|
Diffuse |
0 (0) |
0 (0) |
0 (0) |
|
No of LN metastases |
|
|
|
0.013 |
Median [Range] | 4 [1-100] | 4 [1-100] | 2 [1-10] |